Health Care · Biotechnology
Market capitalization divided by trailing twelve-month revenue. A valuation metric often used when earnings are negative or not meaningful.
Latest P/S Ratio
260.82x
As of Jun 27, 2025
Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/S Ratio |
|---|---|
| Jun 27, 2025 | 260.82x |
| Jun 26, 2025 | 267.44x |
| Jun 25, 2025 | 272.45x |
| Jun 24, 2025 | 277.61x |
| Jun 23, 2025 | 277.93x |
| Jun 20, 2025 | 286.65x |
| Jun 18, 2025 | 295.36x |
| Jun 17, 2025 | 297.30x |
P/S Ratio = Market Capitalization / Revenue (TTM)
P/S ignores profitability and capital structure, making it a simple but blunt valuation tool.
Read the general P/S Ratio definition, formula, and analyst usage guide.
P/S Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison